Public signalCompany raiseAuto-indexed · Unverified

Syncromune, Inc. raised $111.8M

Syncromune, Inc.· FORT LAUDERDALE, US· Biotechnology· Filed Aug 21, 2025

Syncromune, Inc. reported raising capital. Based in FORT LAUDERDALE, FLORIDA, US. First sale reported 2024-12-03. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.

Raised
$111.8M
Confidence90%
Raised
$111.8M
Investors
77
Incorporated
2020
Jurisdiction
DELAWARE

On the record

Location
FORT LAUDERDALE, US
Sector
Biotechnology
Record type
Company raise
Stage
Reported raised
Amount raised
$111.8M
Target amount
$144.8M
Filing date
Aug 21, 2025
Issuer type
operating company

Gaps in the record

  • Valuation and deal terms are not on the public record
  • No company website on record
  • Investors are not disclosed
  • Not yet claimed or verified by the company

Filing details

Jurisdiction of incorporation
DELAWARE
Year incorporated
2020
Industry group
Biotechnology
Number of investors
77
Includes non-accredited investors
No
Revenue range
Decline to Disclose
Total offering amount
$144.8M
Amendment
Yes

People named on this filing

Officers, directors, managers and entities listed in the public filing.

Sources & provenance

Operating company sold 111,828,793 USD under Reg D.

View original filing (SEC EDGAR Form D)

Automatically indexed from SEC EDGAR Form D · filing dated Aug 21, 2025. Details beyond the filing have not been verified.

Tags

AmendmentUSCompanyBiotechnologyOver $100MCompany Raise

Are you associated with Syncromune, Inc.?

This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.

Claim this record